Decode Biology. Guide Treatment.
Explore oncoREVEAL
oncoREVEAL transforms patient multi-omic biology into a treatment response report. By simulating therapies across latent biological space, it helps identify which patient populations are most likely to respond, which treatments show the strongest predicted effect, and why biology may drive sensitivity or resistance.
Reveal Treatment Response from Biology
01
Latent Space
Every patient embedded by biology
oncoREVEAL maps patient multi-omic profiles into latent space, organizing tumors by underlying biological state rather than cancer type alone.
Biology Inputs
Patient Omics
Latent Biology
01
Latent Space
Every patient embedded by biology
oncoREVEAL maps patient multi-omic profiles into latent space, organizing tumors by underlying biological state rather than cancer type alone.
Biology Inputs
Patient Omics
Latent Biology
01
Latent Space
Every patient embedded by biology
oncoREVEAL maps patient multi-omic profiles into latent space, organizing tumors by underlying biological state rather than cancer type alone.
Biology Inputs
Patient Omics
Latent Biology
02
Simulate at Scale
Thousands of drugs and combinations tested in silico
The platform runs large-scale AI-driven simulations across the latent space to evaluate predicted response for therapies, combinations, and biology-defined patient groups.
Simulation Layer
Drug Screens
Combination Models
02
Simulate at Scale
Thousands of drugs and combinations tested in silico
The platform runs large-scale AI-driven simulations across the latent space to evaluate predicted response for therapies, combinations, and biology-defined patient groups.
Simulation Layer
Drug Screens
Combination Models
02
Simulate at Scale
Thousands of drugs and combinations tested in silico
The platform runs large-scale AI-driven simulations across the latent space to evaluate predicted response for therapies, combinations, and biology-defined patient groups.
Simulation Layer
Drug Screens
Combination Models
03
Mechanistic Characterization
Response and resistance mechanisms are explained
The report links predicted response to molecular programs, pathway activity, and biological mechanisms that may explain sensitivity, resistance, or progression.
Mechanistic Insights
Pathways / Resistance
Response Drivers
03
Mechanistic Characterization
Response and resistance mechanisms are explained
The report links predicted response to molecular programs, pathway activity, and biological mechanisms that may explain sensitivity, resistance, or progression.
Mechanistic Insights
Pathways / Resistance
Response Drivers
03
Mechanistic Characterization
Response and resistance mechanisms are explained
The report links predicted response to molecular programs, pathway activity, and biological mechanisms that may explain sensitivity, resistance, or progression.
Mechanistic Insights
Pathways / Resistance
Response Drivers
04
Ranked Report
Treatment options are ranked by predicted response
oncoREVEAL produces a structured report with ranked therapeutic opportunities, cohort-level evidence, and mechanistic rationale for review by clinicians and tumor boards.
Strategy Milestones
Therapy Ranking
Rationale for MTB Review
04
Ranked Report
Treatment options are ranked by predicted response
oncoREVEAL produces a structured report with ranked therapeutic opportunities, cohort-level evidence, and mechanistic rationale for review by clinicians and tumor boards.
Strategy Milestones
Therapy Ranking
Rationale for MTB Review
04
Ranked Report
Treatment options are ranked by predicted response
oncoREVEAL produces a structured report with ranked therapeutic opportunities, cohort-level evidence, and mechanistic rationale for review by clinicians and tumor boards.
Strategy Milestones
Therapy Ranking
Rationale for MTB Review
What is oncoREVEAL?
oncoREVEAL is a tumor-agnostic AI report that reveals the tumor biology behind treatment response. It characterizes patient biology, predicts therapeutic sensitivity, and provides mechanistic rationale for response and resistance.
Who is oncoREVEAL designed for?
oncoREVEAL is designed for patients, physicians, Molecular Tumor Boards, cancer biologists, and oncology teams seeking deeper biological insight into treatment response.
How is oncoREVEAL different from standard genomic reports?
Many genomic reports focus on individual mutations or diagnosis-based treatment options. oncoREVEAL takes a broader biology-first approach, using multi-omic signals and AI simulations to understand treatment response at the systems level.
Can oncoREVEAL support Molecular Tumor Board review?
Yes. oncoREVEAL is designed to provide structured biological evidence, ranked treatment-response insights, and mechanistic rationale that can support Molecular Tumor Board discussion.
What is oncoREVEAL?
oncoREVEAL is a tumor-agnostic AI report that reveals the tumor biology behind treatment response. It characterizes patient biology, predicts therapeutic sensitivity, and provides mechanistic rationale for response and resistance.
Who is oncoREVEAL designed for?
oncoREVEAL is designed for patients, physicians, Molecular Tumor Boards, cancer biologists, and oncology teams seeking deeper biological insight into treatment response.
How is oncoREVEAL different from standard genomic reports?
Many genomic reports focus on individual mutations or diagnosis-based treatment options. oncoREVEAL takes a broader biology-first approach, using multi-omic signals and AI simulations to understand treatment response at the systems level.
Can oncoREVEAL support Molecular Tumor Board review?
Yes. oncoREVEAL is designed to provide structured biological evidence, ranked treatment-response insights, and mechanistic rationale that can support Molecular Tumor Board discussion.
What is oncoREVEAL?
oncoREVEAL is a tumor-agnostic AI report that reveals the tumor biology behind treatment response. It characterizes patient biology, predicts therapeutic sensitivity, and provides mechanistic rationale for response and resistance.
Who is oncoREVEAL designed for?
oncoREVEAL is designed for patients, physicians, Molecular Tumor Boards, cancer biologists, and oncology teams seeking deeper biological insight into treatment response.
How is oncoREVEAL different from standard genomic reports?
Many genomic reports focus on individual mutations or diagnosis-based treatment options. oncoREVEAL takes a broader biology-first approach, using multi-omic signals and AI simulations to understand treatment response at the systems level.
Can oncoREVEAL support Molecular Tumor Board review?
Yes. oncoREVEAL is designed to provide structured biological evidence, ranked treatment-response insights, and mechanistic rationale that can support Molecular Tumor Board discussion.
Request Sample Report
The Greenway, Block C,
112-114 St Stephen's Green,
Dublin 2, D02 TD28
Dublin, Ireland
Decode Biology. Guide Treatment.
Explore oncoREVEAL
oncoREVEAL transforms patient multi-omic biology into a treatment response report. By simulating therapies across latent biological space, it helps identify which patient populations are most likely to respond, which treatments show the strongest predicted effect, and why biology may drive sensitivity or resistance.
Reveal Treatment Response from Biology
01
Latent Space
Every patient embedded by biology
oncoREVEAL maps patient multi-omic profiles into latent space, organizing tumors by underlying biological state rather than cancer type alone.
Biology Inputs
Patient Omics
Latent Biology
01
Latent Space
Every patient embedded by biology
oncoREVEAL maps patient multi-omic profiles into latent space, organizing tumors by underlying biological state rather than cancer type alone.
Biology Inputs
Patient Omics
Latent Biology
01
Latent Space
Every patient embedded by biology
oncoREVEAL maps patient multi-omic profiles into latent space, organizing tumors by underlying biological state rather than cancer type alone.
Biology Inputs
Patient Omics
Latent Biology
02
Simulate at Scale
Thousands of drugs and combinations tested in silico
The platform runs large-scale AI-driven simulations across the latent space to evaluate predicted response for therapies, combinations, and biology-defined patient groups.
Simulation Layer
Drug Screens
Combination Models
02
Simulate at Scale
Thousands of drugs and combinations tested in silico
The platform runs large-scale AI-driven simulations across the latent space to evaluate predicted response for therapies, combinations, and biology-defined patient groups.
Simulation Layer
Drug Screens
Combination Models
02
Simulate at Scale
Thousands of drugs and combinations tested in silico
The platform runs large-scale AI-driven simulations across the latent space to evaluate predicted response for therapies, combinations, and biology-defined patient groups.
Simulation Layer
Drug Screens
Combination Models
03
Mechanistic Characterization
Response and resistance mechanisms are explained
The report links predicted response to molecular programs, pathway activity, and biological mechanisms that may explain sensitivity, resistance, or progression.
Mechanistic Insights
Pathways / Resistance
Response Drivers
03
Mechanistic Characterization
Response and resistance mechanisms are explained
The report links predicted response to molecular programs, pathway activity, and biological mechanisms that may explain sensitivity, resistance, or progression.
Mechanistic Insights
Pathways / Resistance
Response Drivers
03
Mechanistic Characterization
Response and resistance mechanisms are explained
The report links predicted response to molecular programs, pathway activity, and biological mechanisms that may explain sensitivity, resistance, or progression.
Mechanistic Insights
Pathways / Resistance
Response Drivers
04
Ranked Report
Treatment options are ranked by predicted response
oncoREVEAL produces a structured report with ranked therapeutic opportunities, cohort-level evidence, and mechanistic rationale for review by clinicians and tumor boards.
Strategy Milestones
Therapy Ranking
Rationale for MTB Review
04
Ranked Report
Treatment options are ranked by predicted response
oncoREVEAL produces a structured report with ranked therapeutic opportunities, cohort-level evidence, and mechanistic rationale for review by clinicians and tumor boards.
Strategy Milestones
Therapy Ranking
Rationale for MTB Review
04
Ranked Report
Treatment options are ranked by predicted response
oncoREVEAL produces a structured report with ranked therapeutic opportunities, cohort-level evidence, and mechanistic rationale for review by clinicians and tumor boards.
Strategy Milestones
Therapy Ranking
Rationale for MTB Review
What is oncoREVEAL?
oncoREVEAL is a tumor-agnostic AI report that reveals the tumor biology behind treatment response. It characterizes patient biology, predicts therapeutic sensitivity, and provides mechanistic rationale for response and resistance.
Who is oncoREVEAL designed for?
oncoREVEAL is designed for patients, physicians, Molecular Tumor Boards, cancer biologists, and oncology teams seeking deeper biological insight into treatment response.
How is oncoREVEAL different from standard genomic reports?
Many genomic reports focus on individual mutations or diagnosis-based treatment options. oncoREVEAL takes a broader biology-first approach, using multi-omic signals and AI simulations to understand treatment response at the systems level.
Can oncoREVEAL support Molecular Tumor Board review?
Yes. oncoREVEAL is designed to provide structured biological evidence, ranked treatment-response insights, and mechanistic rationale that can support Molecular Tumor Board discussion.
What is oncoREVEAL?
oncoREVEAL is a tumor-agnostic AI report that reveals the tumor biology behind treatment response. It characterizes patient biology, predicts therapeutic sensitivity, and provides mechanistic rationale for response and resistance.
Who is oncoREVEAL designed for?
oncoREVEAL is designed for patients, physicians, Molecular Tumor Boards, cancer biologists, and oncology teams seeking deeper biological insight into treatment response.
How is oncoREVEAL different from standard genomic reports?
Many genomic reports focus on individual mutations or diagnosis-based treatment options. oncoREVEAL takes a broader biology-first approach, using multi-omic signals and AI simulations to understand treatment response at the systems level.
Can oncoREVEAL support Molecular Tumor Board review?
Yes. oncoREVEAL is designed to provide structured biological evidence, ranked treatment-response insights, and mechanistic rationale that can support Molecular Tumor Board discussion.
What is oncoREVEAL?
oncoREVEAL is a tumor-agnostic AI report that reveals the tumor biology behind treatment response. It characterizes patient biology, predicts therapeutic sensitivity, and provides mechanistic rationale for response and resistance.
Who is oncoREVEAL designed for?
oncoREVEAL is designed for patients, physicians, Molecular Tumor Boards, cancer biologists, and oncology teams seeking deeper biological insight into treatment response.
How is oncoREVEAL different from standard genomic reports?
Many genomic reports focus on individual mutations or diagnosis-based treatment options. oncoREVEAL takes a broader biology-first approach, using multi-omic signals and AI simulations to understand treatment response at the systems level.
Can oncoREVEAL support Molecular Tumor Board review?
Yes. oncoREVEAL is designed to provide structured biological evidence, ranked treatment-response insights, and mechanistic rationale that can support Molecular Tumor Board discussion.
Request Sample Report
The Greenway, Block C,
112-114 St Stephen's Green,
Dublin 2, D02 TD28
Dublin, Ireland
Decode Biology. Guide Treatment.
Explore oncoREVEAL
oncoREVEAL transforms patient multi-omic biology into a treatment response report. By simulating therapies across latent biological space, it helps identify which patient populations are most likely to respond, which treatments show the strongest predicted effect, and why biology may drive sensitivity or resistance.
Reveal Treatment Response from Biology
01
Latent Space
Every patient embedded by biology
oncoREVEAL maps patient multi-omic profiles into latent space, organizing tumors by underlying biological state rather than cancer type alone.
Biology Inputs
Patient Omics
Latent Biology
01
Latent Space
Every patient embedded by biology
oncoREVEAL maps patient multi-omic profiles into latent space, organizing tumors by underlying biological state rather than cancer type alone.
Biology Inputs
Patient Omics
Latent Biology
01
Latent Space
Every patient embedded by biology
oncoREVEAL maps patient multi-omic profiles into latent space, organizing tumors by underlying biological state rather than cancer type alone.
Biology Inputs
Patient Omics
Latent Biology
02
Simulate at Scale
Thousands of drugs and combinations tested in silico
The platform runs large-scale AI-driven simulations across the latent space to evaluate predicted response for therapies, combinations, and biology-defined patient groups.
Simulation Layer
Drug Screens
Combination Models
02
Simulate at Scale
Thousands of drugs and combinations tested in silico
The platform runs large-scale AI-driven simulations across the latent space to evaluate predicted response for therapies, combinations, and biology-defined patient groups.
Simulation Layer
Drug Screens
Combination Models
02
Simulate at Scale
Thousands of drugs and combinations tested in silico
The platform runs large-scale AI-driven simulations across the latent space to evaluate predicted response for therapies, combinations, and biology-defined patient groups.
Simulation Layer
Drug Screens
Combination Models
03
Mechanistic Characterization
Response and resistance mechanisms are explained
The report links predicted response to molecular programs, pathway activity, and biological mechanisms that may explain sensitivity, resistance, or progression.
Mechanistic Insights
Pathways / Resistance
Response Drivers
03
Mechanistic Characterization
Response and resistance mechanisms are explained
The report links predicted response to molecular programs, pathway activity, and biological mechanisms that may explain sensitivity, resistance, or progression.
Mechanistic Insights
Pathways / Resistance
Response Drivers
03
Mechanistic Characterization
Response and resistance mechanisms are explained
The report links predicted response to molecular programs, pathway activity, and biological mechanisms that may explain sensitivity, resistance, or progression.
Mechanistic Insights
Pathways / Resistance
Response Drivers
04
Ranked Report
Treatment options are ranked by predicted response
oncoREVEAL produces a structured report with ranked therapeutic opportunities, cohort-level evidence, and mechanistic rationale for review by clinicians and tumor boards.
Strategy Milestones
Therapy Ranking
Rationale for MTB Review
04
Ranked Report
Treatment options are ranked by predicted response
oncoREVEAL produces a structured report with ranked therapeutic opportunities, cohort-level evidence, and mechanistic rationale for review by clinicians and tumor boards.
Strategy Milestones
Therapy Ranking
Rationale for MTB Review
04
Ranked Report
Treatment options are ranked by predicted response
oncoREVEAL produces a structured report with ranked therapeutic opportunities, cohort-level evidence, and mechanistic rationale for review by clinicians and tumor boards.
Strategy Milestones
Therapy Ranking
Rationale for MTB Review
What is oncoREVEAL?
oncoREVEAL is a tumor-agnostic AI report that reveals the tumor biology behind treatment response. It characterizes patient biology, predicts therapeutic sensitivity, and provides mechanistic rationale for response and resistance.
Who is oncoREVEAL designed for?
oncoREVEAL is designed for patients, physicians, Molecular Tumor Boards, cancer biologists, and oncology teams seeking deeper biological insight into treatment response.
How is oncoREVEAL different from standard genomic reports?
Many genomic reports focus on individual mutations or diagnosis-based treatment options. oncoREVEAL takes a broader biology-first approach, using multi-omic signals and AI simulations to understand treatment response at the systems level.
Can oncoREVEAL support Molecular Tumor Board review?
Yes. oncoREVEAL is designed to provide structured biological evidence, ranked treatment-response insights, and mechanistic rationale that can support Molecular Tumor Board discussion.
What is oncoREVEAL?
oncoREVEAL is a tumor-agnostic AI report that reveals the tumor biology behind treatment response. It characterizes patient biology, predicts therapeutic sensitivity, and provides mechanistic rationale for response and resistance.
Who is oncoREVEAL designed for?
oncoREVEAL is designed for patients, physicians, Molecular Tumor Boards, cancer biologists, and oncology teams seeking deeper biological insight into treatment response.
How is oncoREVEAL different from standard genomic reports?
Many genomic reports focus on individual mutations or diagnosis-based treatment options. oncoREVEAL takes a broader biology-first approach, using multi-omic signals and AI simulations to understand treatment response at the systems level.
Can oncoREVEAL support Molecular Tumor Board review?
Yes. oncoREVEAL is designed to provide structured biological evidence, ranked treatment-response insights, and mechanistic rationale that can support Molecular Tumor Board discussion.
What is oncoREVEAL?
oncoREVEAL is a tumor-agnostic AI report that reveals the tumor biology behind treatment response. It characterizes patient biology, predicts therapeutic sensitivity, and provides mechanistic rationale for response and resistance.
Who is oncoREVEAL designed for?
oncoREVEAL is designed for patients, physicians, Molecular Tumor Boards, cancer biologists, and oncology teams seeking deeper biological insight into treatment response.
How is oncoREVEAL different from standard genomic reports?
Many genomic reports focus on individual mutations or diagnosis-based treatment options. oncoREVEAL takes a broader biology-first approach, using multi-omic signals and AI simulations to understand treatment response at the systems level.
Can oncoREVEAL support Molecular Tumor Board review?
Yes. oncoREVEAL is designed to provide structured biological evidence, ranked treatment-response insights, and mechanistic rationale that can support Molecular Tumor Board discussion.
Request Sample Report
The Greenway, Block C,
112-114 St Stephen's Green,
Dublin 2, D02 TD28
Dublin, Ireland